Kunal Kandimalla

Kunal Kandimalla currently serves as Vice President of Public and Private Biotech Investments at Perceptive Advisors since April 2018. Prior experience includes a consultant role in Global Rare Disease Hematology at Sanofi Genzyme in 2017, corporate strategy at Novartis in 2016, and business development and operations at Agios Pharmaceuticals from January 2014 to July 2015. Kunal began a career in life sciences strategy as a consultant at Putnam Associates from September 2010 to January 2014. Academic qualifications include an M.B.A. in Healthcare Management, Finance, and Entrepreneurial Management from The Wharton School (2015-2017) and a B.A. in Economics with Honors, Healthcare Management, and Biological Basis of Behavior from the University of Pennsylvania (2006-2010). Kunal is a graduate of Grapevine High School (2002-2006).